First Time Loading...

Ocular Therapeutix Inc
NASDAQ:OCUL

Watchlist Manager
Ocular Therapeutix Inc Logo
Ocular Therapeutix Inc
NASDAQ:OCUL
Watchlist
Price: 6.1 USD -3.02% Market Closed
Updated: May 22, 2024

Ocular Therapeutix Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ocular Therapeutix Inc
Gross Profit Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
Ocular Therapeutix Inc
NASDAQ:OCUL
Gross Profit
$54.4m
CAGR 3-Years
40%
CAGR 5-Years
102%
CAGR 10-Years
121%
Johnson & Johnson
NYSE:JNJ
Gross Profit
$59.6B
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Gross Profit
$34.6B
CAGR 3-Years
2%
CAGR 5-Years
16%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Gross Profit
$38.8B
CAGR 3-Years
55%
CAGR 5-Years
N/A
CAGR 10-Years
-1%
Merck & Co Inc
NYSE:MRK
Gross Profit
$46B
CAGR 3-Years
17%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
Gross Profit
$28.8B
CAGR 3-Years
14%
CAGR 5-Years
11%
CAGR 10-Years
5%

See Also

What is Ocular Therapeutix Inc's Gross Profit?
Gross Profit
54.4m USD

Based on the financial report for Mar 31, 2024, Ocular Therapeutix Inc's Gross Profit amounts to 54.4m USD.

What is Ocular Therapeutix Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
121%

Over the last year, the Gross Profit growth was 15%. The average annual Gross Profit growth rates for Ocular Therapeutix Inc have been 40% over the past three years , 102% over the past five years , and 121% over the past ten years .